Healthcare Compliance

Ypsomed AG EP4548948A1 Fluid Administration Device, Apr 15

The European Patent Office published patent application EP4548948A1 by Ypsomed AG for a fluid administration device on April 15, 2026. The application names six inventors: Peter Loser, Markus Tschirren, Christian Schrul, Oliver Glauser, Dominik Zumstein, and Simon Martin Bosshard, classified under IPC A61M. The application is designated across EU and EEA states including Germany, France, and the United Kingdom.

Cequr SA Bolus Dose Microfluidic Pump Patent EP4275716A2

European Patent Office published patent application EP4275716A2 filed by Cequr SA covering a bolus dose microfluidic pump for medical device applications. The application was published on April 15, 2026 under IPC classifications A61M 5/168 and A61M 5/142. Protection is sought across 35 designated states including all EU member states plus Switzerland, Norway, Turkey, and other European Patent Convention states. Eight inventors are named: Pretorius, Farra, Barnett, Piper, Ford, Solomon, Holst, and Smith.

Cannula Insertion Mechanism, EP4257163A2, mylife Diabetes Care

The EPO published patent application EP4257163A2 titled 'Cannula Insertion Mechanism' filed by mylife Diabetes Care AG, published April 15, 2026. Inventors listed are Buri, Thomas; Hostettler, Patrick; Hofer, Christophe; Streit, Ursina; Staub, Seline; and Steck, Jürg. The application is classified under IPC A61M 5/32, A61M 5/158, and A61M 5/142, covering medical device mechanisms for subcutaneous cannula insertion. Designated states cover most EU/EEA member states plus the United Kingdom and other EPC contracting states.

Inhaler with Retention Element - Aspeya US Inc. EP4561656A1

The European Patent Office published patent application EP4561656A1 titled 'AN INHALER COMPRISING A RETENTION ELEMENT' filed by Aspeya US Inc. The application, filed with inventors Philip John Swanbury, Kambiz Yadidi, and Mo Aydin, has been classified under IPC A61M 15/00 (inhalers) and designates 31 European states including DE, FR, GB, IT, ES, NL, SE, and others.

Sanofi EP4241809A2 Supplementary Device for Attachment to an Injection Device

Sanofi filed patent application EP4241809A2 for a supplementary device for attachment to an injection device, classified under IPC A61M (medical devices for administering medicines). The application was published on April 15, 2026 and designates all EU member states along with Iceland, Norway, Switzerland, Turkey, and the United Kingdom. The sole inventor listed is Ilario Melzi.

EP4238597A2 Drug Delivery Device with Audible Indicator

European Patent EP4238597A2 was published on April 15, 2026 by the European Patent Office. The patent, filed by Sanofi-Aventis Deutschland GmbH, covers a drug delivery device with an audible indicator mechanism. Inventors are MOSEBACH, Carsten and KEMP, Thomas Mark, with IPC classifications A61M 5/24 and A61M 5/20.

Artificial Heart Valve, EP2024067809A1, Apr 15

The EPO published patent application EP2024067809A1 for an artificial heart valve (IPC A61F 2/24) filed by Biotyx Medical (Shenzhen) Co., Ltd. The application designates 27 European states and was published on April 15, 2026. The designation of inventor has not yet been filed.

Boston Scientific Stent Patent, EP4593769A1, Published Apr 15, 2026

The European Patent Office granted patent EP4593769A1 to Boston Scientific Scimed Inc. for a stent system designed to maintain patency of a body lumen. The patent, published April 15, 2026, names inventors Folan, Root, McNern, and Tuck, and covers IPC classifications A61F 2/852, A61F 2/88, and A61M 27/00. Designation extends across all specified European member states including DE, FR, GB, and IT.

Glenoid Replacement System Patent, ARCA By OrthoAgile, Apr 2026

The European Patent Office published patent EP4586968A1, granting ARCA By OrthoAgile LLC exclusive rights to a glenoid replacement system and methods of implanting said glenoid replacement. The patent names JONES, Andrew as the sole inventor and designates 35 contracting states including DE, FR, GB, IT, NL, ES, BE, AT, CH, and others. This represents a newly registered intellectual property right in the field of medical device technology for shoulder joint replacement procedures. Medical device manufacturers and healthcare providers operating in the EU should note that ARCA By OrthoAgile LLC now holds enforceable exclusive rights to this glenoid replacement technology. The 35-state designation makes this commercially significant for the applicant, while competitors developing or marketing similar shoulder arthroplasty products should review the patent claims to assess freedom-to-operate.

Prosthetic Heart Valve, Magnolia Medical Corp., EP4518804A2

The European Patent Office published patent application EP4518804A2 filed by Magnolia Medical Corp. for a prosthetic heart valve system on April 15, 2026. The application, designating 39 states including all EU member states, names Glen Rabito, Hieu Luong, and Robert Taft as inventors under IPC classification A61F 2/24 (heart valve prostheses).

Elbow Prosthesis Implant, EP4507631A1, April 2026

The European Patent Office published patent application EP4507631A1 titled 'Elbow Prosthesis Implant' on April 15, 2026. The application names Semmelweis Egyetem and Budapesti Müszaki és Gazdaságtudományi Egyetem as co-applicants, with KOCSIS György, SZEBÉNYI Gábor, and TEMESI Tamás listed as inventors. The application covers IPC classifications A61F 2/38 and A61F 2/30 relating to elbow joint prostheses and associated joint components.

Interbody Spinal Implant Patent, Warsaw Orthopedic, EP4561504A1, Apr 15, 2026

The European Patent Office granted patent EP4561504A1 to Warsaw Orthopedic, Inc. on April 15, 2026, covering an interbody spinal implant design with endplates connected by struts. The patent lists six inventors: Miller, Keith; Wolfe, Thomas; Metcalf, Newton; Ballard, Rodney; Prevost, Julien; and Beale, Jeffrey. Medical device manufacturers developing or marketing spinal interbody fusion devices in Europe should review this patent for potential freedom-to-operate implications.

Heart Valve Prosthesis, EP3568107A1, Published April 15, 2026

The European Patent Office granted patent EP3568107A1 on April 15, 2026, to Mitrassist Medical Ltd. for a heart valve prosthesis invention classified under IPC A61F 2/24 (circulatory system prosthetic devices). The inventors are NAOR, Gil and MEYER-BRODNITZ, Gideon. The patent is designated for all EU member states, granting exclusive rights to the applicant for the protected technology.

HVR Cardio Oy Heart Valve Patent EP4522083A1

The European Patent Office published patent application EP4522083A1 on April 15, 2026, titled 'A MEDICAL DEVICE FOR IMPROVING FUNCTION OF A HEART VALVE.' The patent was filed by HVR Cardio Oy with inventor Keränen Olli, classified under IPC A61F 2/24. The patent designates 31 European contracting states including major markets such as Germany, France, the United Kingdom, Italy, Spain, and the Netherlands.

Quorum Orthopedics 3D Printed Prosthetic Liner Patent EP4518812A1

The EPO has published patent application EP4518812A1 titled 'System and Methods for Treating a 3D Printed Prosthetic Liner' by Quorum Orthopedics, Inc. as applicant. The patent covers systems and methods for treating prosthetic liners manufactured via 3D printing. Inventors are listed as Joe Johnson, John Fleischmann, and Sean McClure. The patent is designated for 37 European states including Germany, France, Italy, Spain, UK, Netherlands, Belgium, Sweden, Austria, Poland, and Ireland.

Prosthetic Control Via Amplified Nerve Signals, EP4486259A1

The European Patent Office granted Patent EP4486259A1 to The Regents of the University of Michigan on April 15, 2026. The patent covers systems and methods for controlling a prosthetic device using amplified nerve signals, with inventors including Cynthia Anne Chestek, Paul S. Cederna, Philip Vu, and Alex Vaskov. The designated states cover all EU member states plus several other European countries. This patent grants exclusive rights to the patented prosthetic control technology for the defined European territory.

Prosthetic Hand Device Using Wearable Ultrasound Module as Human Machine Interface

The European Patent Office published application EP4648720A1 filed by The Hong Kong Polytechnic University, covering a prosthetic hand device that uses a wearable ultrasound module as a human machine interface. The technology maps muscle activity via ultrasound to provide intuitive, low-latency control signals for prosthetic hand movement. Named inventors are NAZARI, Vaheh, ZHENG, Yongping, and SHEA, Tsung Kwan. The application was published April 15, 2026 under IPC classifications A61F 2/54, A61F 2/70, and A61F 2/72, designating 33 European Patent Convention member states.

Sensorized Knee Arthroplasty System with Intraoperative Sensors, DePuy Ireland, EP4554520A2

DePuy Ireland Unlimited Company has received A2 publication (publication without search report) for EP4554520A2 titled 'Sensorized Knee Arthroplasty Utilizing an Intraoperative Sensor System', filed with the European Patent Office on April 15, 2026. The invention covers an intraoperative sensor system for knee replacement procedures, classified under A61F 2/38 (knee prostheses) and A61B 5/103 (measuring for diagnostic purposes). The patent application designates all EPC contracting states including AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, and SM. As an A2 publication, the application is publicly available but the search report has not yet been published.

PAHO Strengthens ICD-11 Capacity Building for Mortality Coding Across the Americas

PAHO launched the course "Training of ICD-11 coders and its tools: mortality component for the Americas" in Mexico City on April 22, 2026. The hybrid training brings together representatives from 17 countries and 30 states of Mexico, with an in-person phase from April 20–24 in Mexico City and a virtual phase running through July 2026. The initiative is part of PAHO's Plan of Action for Strengthening Information Systems for Health 2030, supported by Data for Health (D4H) Bloomberg Philanthropies, and aims to strengthen technical capacities for implementing ICD-11 in mortality data recording and analysis across the Region.

Jamaica Observes 24th Vaccination Week in the Americas

Jamaica joins PAHO and global partners from April 25 to May 2, 2026, to observe the 24th Vaccination Week in the Americas and 15th World Immunization Week under the theme 'Your decision makes a difference. Immunization for all.' The observance supports the Disease Elimination Initiative targeting elimination of over 30 communicable diseases by 2030, including 11 vaccine-preventable diseases. Key activities include a main vaccination outreach event on April 30 in Port Maria, St. Mary, and a regional Caribbean Vaccination Week launch broadcast on April 25, 2026 at 8:00 a.m. Jamaica time.

AI Virtual Medical Advisor System With Adaptive Therapeutic Audio and Biometric Monitoring

The USPTO granted Patent US12609103B1 to inventor Michael P. Tabibian on April 21, 2026, covering an AI-driven system that creates personalized virtual medical and spiritual advisor avatars using deepfake technology, multimodal deep neural networks, natural language processing, and biometric monitoring. The virtual medical advisor analyzes unstructured electronic health records with BERT-based techniques while adapting communication based on real-time physiological data from sensors including EEG and photoplethysmography. The system additionally features gamification with cryptocurrency or NFT rewards, blockchain-based audit trails for HIPAA compliance, federated learning with differential privacy, 3D anatomical simulations for pharmacokinetics, and adaptive audio treatments in AR/VR environments, all optimized through reinforcement learning across 19 claims.

Hospital Room Monitoring Patent, Clinomic Medical, Apr 21

USPTO granted patent US12610442B2 to Clinomic Medical GmbH for a method combining presence monitoring and environmental monitoring in a hospital room. The system detects persons or devices via markers, measures environmental parameters, and controls a lighting array based on detection and measurement data. The patent contains 14 claims with CPC classifications H05B 47/115, G16H 40/67, and G16H 40/00. For manufacturers developing similar hospital room monitoring or IoT-based healthcare facility technologies, this grant establishes IP constraints that may require licensing consideration.

Fujifilm X-ray Patent Enables Real-time 3D Tool Tracking

USPTO granted patent US12599347B2 to FUJIFILM Corporation on April 14, 2026, for an X-ray imaging apparatus enabling real-time 3D position tracking of treatment tools during medical operations. The system uses two X-ray tubes—one stationary and one rotating along a circular orbit—to calculate three-dimensional tool positions without rotating the tube column. The patent names Isao Takahashi, Kazuki Matsuzaki, Keisuke Yamakawa, and Tadashi Nakamura as inventors.

US12599448B2 - Robot Surgical Control System - Beijing Surgery Robotics

The USPTO granted Patent US12599448B2 to Beijing Surgery Robotics Company Limited on April 14, 2026, covering an operation enabling control system and robot-assisted surgical device. The system uses a switch element and logic AND circuit to manage power flow to the automated driving system of a surgical robot, with the AND circuit receiving sensor status and control signals to determine switch activation. The patent contains 9 claims and was filed on December 27, 2019.

Patent US12599342B2 - Patient Falls Risk Notification System by Hill-Rom

The USPTO granted patent US12599342B2 to Hill-Rom Services, Inc. on April 14, 2026. The patent covers a patient request system including a tablet computer configured to display menu-based patient requests, a server to receive requests, and a notification device to display requests to caregivers. The system also incorporates patient falls risk notification and caregiver notes access functionality.

USPTO Grants AI Medical Imaging Patent to OMNI MEDSCI

The USPTO granted Patent US12599305B2 to OMNI MEDSCI, INC. on April 14, 2026. The patent covers 3D cameras or sensors as inputs to multi-modal generative artificial intelligence models trained on images or videos, using vision transformers with self-attention and positional encoding layers. The GAI performs data fusion combining 3D information with other sensor data and anomalous occurrence detection by detecting differences in images or videos that fall outside threshold values, while providing safeguards for privacy issues. The patent contains 7 claims and covers CPC classifications in A61B (medical measuring/diagnostics), G01J (optics/spectroscopy), G01N (chemical analysis), G16H (health informatics), and H01S (lasers).

Cleerly Cardiovascular Plaque Analysis Patent, Apr 14

The USPTO granted patent US12599352B2 to Cleerly, Inc. on April 14, 2026. The patent covers systems, devices, and methods for non-invasive image-based plaque analysis and risk determination using computer vision and machine learning to identify, diagnose, characterize, treat, and track coronary artery disease. Inventors are James K. Min and James P. Earls, with 20 claims in the granted patent.

OPTOS PLC Volumetric OCT Image Data Processing Patent Granted

The USPTO granted Patent US12599302B2 to OPTOS PLC on April 14, 2026, covering a method of processing volumetric C-scan OCT image data. The patent claims a technique for compensating axial displacements between B-scans caused by relative motion during OCT acquisition, using indicators of axial shift between adjacent B-scans to determine a first frequency component indicative of motion. The patent names inventors Praveen Ashok and Alan Anderson and contains 24 claims.

Koninklijke Philips N.V. Blood Perfusion Imaging Device Patent US12599310B2

USPTO granted Patent US12599310B2 to Koninklijke Philips N.V. on April 14, 2026, covering a device, method, and systems for imaging blood perfusion by combining widefield imaging and radial imaging to estimate signal source depth. The patent names Willem Verkruijsse, Mark Josephus Henricus van Gastel, and Age Jochem van Dalfsen as inventors, with an application filed December 7, 2021. The technology addresses signal ambiguity in existing photoplethysmography and speckle contrast perfusion imaging systems by providing more accurate combined imaging.

US12599319B2 - Electrochemical Medical Diagnostics Sensor

USPTO granted Patent US12599319B2 to B.G. NEGEV TECHNOLOGIES AND APPLICATIONS LTD., AT BEN-GURION UNIVERSITY on April 14, 2026. The patent covers an electrochemical sensor comprising a counter electrode, optional reference electrode, and array of multiple working electrodes, with at least one being a film-coated electrode using a film-forming material with a six-membered non-aromatic ring repeat unit. The invention includes a device for electrochemical detection (electrochemical tongue) and a method for detecting analytes. The patent contains 29 claims and was filed as Application No. 16618944 on June 4, 2018.

Six Animals Test Positive for Rabies in Rhode Island

The Rhode Island Department of Health announced that six animals tested positive for rabies in Rhode Island. The announcement provides this count as the factual outcome of animal disease testing conducted by the department. No further details about the specific animals, locations, or dates of testing are included in the source.

Boil Water Advisory Issued for Stone Bridge Fire District, Tiverton

The Rhode Island Department of Health has issued a Boil Water Advisory for the Stone Bridge Fire District service area in Tiverton, Rhode Island. The advisory instructs affected residents and businesses to boil water before consumption due to a confirmed or suspected water quality issue. No specific cause, contamination level, or affected population count is provided in this notice.

VA Privacy Act 1974 Matching Program Correction

The Department of Veterans Affairs published a correction on April 24, 2026, to Notice Document 2026-07012, which originally appeared in the Federal Register on Friday, April 10, 2026 (pages 18530-18531). The correction updates the 'Subject-Line' in the document heading on page 18530, third column. This is an administrative correction to a previously published Privacy Act 1974 Matching Program notice. The corrected notice is identified by FR Doc. C1-2026-07012, filed on April 23, 2026.

Wadsworth Scientist Contributes to National NASEM Report on Red Hill Jet Fuel Water Contamination, Hawaii

The National Academies of Sciences, Engineering, and Medicine published a report titled 'Clinical Follow-up and Care for Those Impacted by the JP-5 Releases at Red Hill,' urging clinicians to prioritize ongoing symptom evaluation for individuals exposed to jet fuel-contaminated drinking water in Honolulu, Hawaii in 2021. The Red Hill Bulk Fuel Storage Facility contamination event affected the drinking water supply serving Joint Base Pearl Harbor-Hickam and surrounding communities, where as many as 93,000 individuals may have been exposed through ingestion, inhalation of vapors, or skin contact. Dr. Kurunthachalam Kannan of the Wadsworth Center's Division of Environmental Health Sciences served on the NASEM committee that developed recommendations for the clinical follow-up and care of impacted individuals, providing guidance to the Department of Defense and the Department of Veterans Affairs.

Dr. Thomas Bartlett Awarded NY Community Trust Grant for MRSA Research

Dr. Thomas Bartlett, a Principal Investigator in the Wadsworth Center's Division of Genetics, has been awarded a two-year New York Community Trust grant for research targeting antibiotic-resistant Staphylococcus aureus. The research focuses on understanding how S. aureus spatially and temporally regulates cell division to identify vulnerabilities exploitable for next-generation antimicrobial development against MRSA and other resistant infections. This represents an investment in protecting the health of New Yorkers through foundational scientific research at the Wadsworth Center.

SSRI Listening Session Minutes – March 24, 2026

The FDA's Center for Drug Evaluation and Research (CDER) published minutes from an SSRI listening session held on March 24, 2026, along with three associated attachments. The materials include an overview of a petition (FDA-2025-P-3956) requesting balanced, evidence-based pregnancy warnings for serotonergic reuptake inhibitors, and a presentation on safely deprescribing psychiatric drugs. The session reflects ongoing FDA engagement with stakeholders on the petition but does not constitute a formal agency decision.

FDA CTP Files Complaint Under Docket FDA-2026-H-4365-0001

A complaint was filed with the Food and Drug Administration under docket FDA-2026-H-4365-0001 on April 24, 2026. The filing is attributed to CTP (Center for Tobacco Products), a operating division within FDA. The source indicates that no documents are currently available to view or download from this docket, preventing review of the complaint's substance or the parties involved.

FDA Attachment 1, Background Material, Apr 23

FDA pre-submission docket FDA-2026-P-4566 includes Attachment 1 as background material. The source document provides only a download link to a PDF; no substantive text content is present in the record. The attachment appears to support a pre-submission filing or petition pending review by FDA.

FDA CDER Acknowledgment Letter to Annora Pharma

FDA CDER issued an acknowledgment letter to Annora Pharma Private Limited dated April 24, 2026. The acknowledgment appears in connection with docket FDA-2026-P-4574, indicating receipt of a pre-submission package or IND submission for review. No substantive regulatory determinations or compliance obligations are contained in this acknowledgment document.

CDER SSRI Listening Session Minutes, March 24, 2026

FDA CDER held a listening session on March 24, 2026 regarding SSRIs (Selective Serotonin Reuptake Inhibitors). The session included a presentation by AbuDagga A. on a petition requesting balanced evidence-based pregnancy warnings for SRIs, and a presentation by Horowitz M. on safe psychiatric drug deprescribing. The main Regulations.gov page displays no downloadable document body despite three listed attachments. This record appears to be an administrative docket entry for the session rather than substantive regulatory action.

FDA Complaint, Docket FDA-2026-H-4360, Apr 24

A complaint was filed with the Food and Drug Administration under docket FDA-2026-H-4360 on April 24. The complaint was authored by CTP (Center for Tobacco Products). The Regulations.gov page shows no documents available for inline viewing; only a downloadable complaint attachment is accessible. The substantive content and basis of the complaint are not visible in this filing record.

SSRI Listening Session Minutes, March 24, 2026

FDA CDER published minutes from an SSRI (Selective Serotonin Reuptake Inhibitor) listening session held on March 24, 2026. The session included presentations by A. AbuDagga on a petition to require balanced evidence-based pregnancy warnings for SSRIs and by M. Horowitz on safe deprescribing of psychiatric drugs. Three PDF attachments are available in the docket: the listening session minutes, AbuDagga's petition overview, and Horowitz's deprescribing presentation.

FDA DMB Acknowledgment Letter to Aurobindo Pharma USA, Inc.

FDA's Division of Manufacturing and Biotechnology (DMB) issued an acknowledgment letter to Aurobindo Pharma USA, Inc. in connection with submission FDA-2026-P-4566. The document was filed under CDER (Center for Drug Evaluation and Research) authorship on Regs.gov. No documents are available for viewing or download, indicating this may be a procedural filing or pre-submission acknowledgment.

FDA DMB Acknowledges Lachman Consultant Services Submission

FDA's Division of Manufacturing and Budget (DMB) issued an acknowledgement letter to Lachman Consultant Services, Inc., confirming receipt of a submission filed under docket FDA-2026-P-4567. The acknowledgement was issued by CDER (Center for Drug Evaluation and Research). The actual letter content is available only as an attachment (attachment_1.pdf) and not displayed in the record page. No substantive regulatory action, deadline, or obligation is described in the visible document metadata.

FDA Withdraws Three ANDAs From Egis Pharmaceuticals and Ambix Laboratories

The Food and Drug Administration (FDA) is withdrawing approval of three abbreviated new drug applications (ANDAs) from two holders — Egis Pharmaceuticals Ltd. of Budapest, Hungary and Ambix Laboratories of Totowa, New Jersey — effective April 24, 2026. The withdrawals affect ANDA 074748 (Captopril tablets, 12.5/25/50/100 mg), ANDA 074808 (Piroxicam capsules, 10/20 mg), and ANDA 060453 (Bacitracin-neomycin sulfate-polymyxin B sulfate ointment with diperodon hydrochloride). FDA determined that the holders repeatedly failed to submit required annual reports under 21 CFR 314.81 and 314.98, and waived their opportunity for a hearing under 21 CFR 314.200.

Senores Pharmaceuticals Completeness Assessment Correspondence

FDA CDER issued a completeness assessment correspondence to Senores Pharmaceuticals, Inc. on April 24, 2026, regarding submission FDA-2026-P-3665. The correspondence documents the agency's review of the completeness of the submitted application materials. No documents are available for public viewing or download at this time.

FDA CDER SSRI Listening Session Minutes, March 24, 2026

FDA's Center for Drug Evaluation and Research (CDER) convened an SSRI (Selective Serotonin Reuptake Inhibitor) listening session on March 24, 2026, publishing minutes and three related presentations. Topics addressed included a petition for balanced evidence-based pregnancy warnings on serotonergic drugs and methods for safely deprescribing psychiatric medications. The documents were made available via Regulations.gov docket FDA-2025-P-1305-0288.

Two Measles Cases Confirmed in Maryland Residents with Recent Out-of-State Travel

The Maryland Department of Health announced two confirmed measles cases in Maryland residents of the Baltimore metro area who recently traveled to a U.S. location with active measles transmission. Health officials have identified nine exposure locations including Giant Foods Pasadena, Bean Rush Cafe, Whole Foods Annapolis, and several medical facilities in the Annapolis and Glen Burnie areas, spanning April 12-21, 2026. Exposed individuals should monitor for symptoms for 21 days, verify MMR vaccination status, and contact healthcare providers before visiting medical facilities if symptoms develop.

Company Fined $2,500 for Failing to Comply with Ahpra Investigation

A West Australian court has upheld AHPRA's power to compel evidence production during investigations, marking the first prosecution for this offence under the National Law. Siena Beauty Pty Ltd was fined $2,500 and ordered to pay $5,000 in legal costs after pleading guilty to failing to comply with a Schedule 5 Notice to Produce Information. The company, a practice management company for a registered health practitioner's clinic, failed to provide financial records regarding supplements and alternative treatments despite receiving multiple extensions of time.

Warrant Issued for Banned Occupational Therapist Misheck Mukonoweshuro

NSW man Misheck Mukonoweshuro has been found guilty of four counts related to practising as an occupational therapist while banned, including one count of unlawfully holding himself out as a registered occupational therapist between 12 April 2023 and 6 May 2024. After failing to appear in Liverpool Local Court in March 2026 and again on 10 April 2026, a warrant was issued for his arrest to be brought before the court for sentencing. His registration was previously cancelled by the Civil and Administrative Tribunal NSW in July 2025, prohibiting him from providing health services for five years.